Epidemiologia Molecular

Mida actual: 100%

idioma:

CONTINGUT

Epidemiologia Molecular

Publicacions

Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes
Roger Paredes^1,2,3, Vincent C. Marconi^4,5,6, Shahin Lockman^7,8,9, Elaine J. Abrams^10,11 and Louise Kuhn^10,12

¹IrsiCaixa AIDS Research Institute ²HIV Unit, Internal Medicine Department, Hospital Universitari Germans Trias i Pujol ³Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain ⁴Division of Infectious Diseases, Emory University School of Medicine ⁵Department of Global Health, Rollins School of Public Health, Emory University ⁶Atlanta Veterans Affairs Medical Center, Atlanta, Georgia ⁷Brigham and Women's Hospital ⁸Harvard School of Public Health, Boston, Massachusetts ⁹Botswana Harvard School of Public Health AIDS Initiative Partnership, Gaborone, Botswana ¹⁰Department of Epidemiology, Mailman School of Public Health, Columbia University ¹¹Department of Pediatrics, College of Physicians & Surgeons, Columbia University ¹²Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York
doi: 10.1093/infdis/jit110
Mortality in Well Controlled HIV in the Continuous Antiretroviral Therapy Arms of the SMART and ESPRIT Trials Compared to the General Population

Rodger, Alison¹; Lodwick, Rebecca¹; Schechter, Mauro²; Deeks, Steven³; Amin, Janaki⁴; Gilson, Richard¹; Paredes, Roger⁵; Bakowska, Elzbieta⁶; Engsig, Frederik N.⁷; Phillips, Andrew¹; for the INSIGHT SMART, ESPRIT Study Groups

¹ University College London, London, UK ² Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil ³ The University of California, San Francisco, CA, US ⁴ University of New South Wales, Sydney, Australia ⁵ IrsiCaixa AIDS Research Institute, Badalona, Spain ⁶Wojewodzki Szpital Zakazny, Warsaw, Poland ⁷Frederik N Engsig, Copenhagen University Hospital, Copenhagen, Denmark

Read abstract online in AIDS (full article available in PDF for a limited time)
DOI:10.1097/QAD.0b013e32835cae9c
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32
Ballana E, Riveira-Munoz E, Pou C, Bach V, Parera M, Noguera M, Santos JR, Badia R, Casadellà M, Clotet B, Paredes R, Martínez MA, Brander C, Esté JA.
IrsiCaixa and AIDS Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
Immunobiology(2012). DOI:10.1016/j.imbio.2012.06.012.
Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects
Francisco M. Codoñer, Christian Pou, Alexander Thielen, Federico García, Rafael Delgado, David Dalmau, Miguel Álvarez-Tejado, Lidia Ruiz, Bonaventura Clotet, Roger Paredes
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure
Roger
JAMA, April 6, 2011—Vol 305, No. 13

IrsiCaixa

Destacados

Epidemiologia Molecular

Publicacions

Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes

doi: 10.1093/infdis/jit110

Mortality in Well Controlled HIV in the Continuous Antiretroviral Therapy Arms of the SMART and ESPRIT Trials Compared to the General Population

DOI:10.1097/QAD.0b013e32835cae9c

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32

Immunobiology(2012). DOI:10.1016/j.imbio.2012.06.012.

Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects

Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

JAMA, April 6, 2011—Vol 305, No. 13